Insider · CIK 0001950232

Reardon Andrew

Reports to the SEC for 1 company · JUPITER, FL

sec.gov

Transactions

Companies

Filings

CIK

0001950232

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-02	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	CLO & Secretary	MExercise/Conversion	+340 sh	$52.27	+$17.8K	36,854
2026-10-02	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−833 sh	$302.51	−$252K	36,021
2026-10-02	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−1,976 sh	$303.54	−$600K	34,045
2026-10-02	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−1,535 sh	$304.52	−$467K	32,510
2026-10-02	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−404 sh	$306.18	−$124K	32,106
2026-10-02	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−235 sh	$307.19	−$72.2K	31,871
2026-10-02	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−17 sh	$307.74	−$5,231.58	31,854
2026-10-02	LGNDLIGAND PHARMACEUTICALS INC · Employee Stock Option (right to buy)M Exercise/Conversion	CLO & Secretary	MExercise/Conversion	−340 sh	—	—	29,104
2026-09-03	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−300 sh	$283.99	−$85.2K	41,214
2026-09-03	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−1,800 sh	$285.17	−$513K	39,414
2026-09-03	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−2,115 sh	$286.36	−$606K	37,299
2026-09-03	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−385 sh	$287.53	−$111K	36,914
2026-09-03	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−400 sh	$288.98	−$116K	36,514
2026-08-03	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	CLO & Secretary	MExercise/Conversion	+5,000 sh	$52.27	+$261K	46,514
2026-08-03	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−105 sh	$284.14	−$29.8K	46,409
2026-08-03	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−33 sh	$284.55	−$9,390.249	46,376
2026-08-03	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−157 sh	$285.74	−$44.9K	46,219
2026-08-03	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−1,032 sh	$286.80	−$296K	45,187
2026-08-03	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−1,214 sh	$287.77	−$349K	43,973
2026-08-03	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−356 sh	$288.75	−$103K	43,617
2026-08-03	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−503 sh	$289.80	−$146K	43,114
2026-08-03	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−200 sh	$290.60	−$58.1K	42,914
2026-08-03	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−991 sh	$291.71	−$289K	41,923
2026-08-03	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−409 sh	$292.82	−$120K	41,514
2026-08-03	LGNDLIGAND PHARMACEUTICALS INC · Employee Stock Option (right to buy)M Exercise/Conversion	CLO & Secretary	MExercise/Conversion	−5,000 sh	—	—	29,444
2026-07-01	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	CLO & Secretary	MExercise/Conversion	+5,000 sh	$52.27	+$261K	46,514
2026-07-01	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−396 sh	$308.99	−$122K	46,118
2026-07-01	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−104 sh	$310.20	−$32.3K	46,014
2026-07-01	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−1,119 sh	$311.72	−$349K	44,895
2026-07-01	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−1,081 sh	$312.28	−$338K	43,814
2026-07-01	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−700 sh	$313.46	−$219K	43,114
2026-07-01	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−100 sh	$314.58	−$31.5K	43,014
2026-07-01	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−900 sh	$315.78	−$284K	42,114
2026-07-01	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−600 sh	$317.15	−$190K	41,514
2026-07-01	LGNDLIGAND PHARMACEUTICALS INC · Employee Stock Option (right to buy)M Exercise/Conversion	CLO & Secretary	MExercise/Conversion	−5,000 sh	—	—	34,444
2026-06-30	LGNDLIGAND PHARMACEUTICALS INCJ Other	CLO & Secretary	JOther	+132 sh	$160.71	+$21.2K	41,514
2026-06-01	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	CLO & Secretary	MExercise/Conversion	+5,000 sh	$52.27	+$261K	46,382
2026-06-01	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−491 sh	$223.95	−$110K	45,891
2026-06-01	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−677 sh	$225.20	−$152K	45,214
2026-06-01	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−1,432 sh	$225.97	−$324K	43,782
2026-06-01	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−400 sh	$226.78	−$90.7K	43,382
2026-06-01	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−584 sh	$228.57	−$133K	42,798
2026-06-01	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−1,216 sh	$229.47	−$279K	41,582
2026-06-01	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−200 sh	$230.41	−$46.1K	41,382
2026-06-01	LGNDLIGAND PHARMACEUTICALS INC · Employee Stock Option (right to buy)M Exercise/Conversion	CLO & Secretary	MExercise/Conversion	−5,000 sh	—	—	39,444
2026-05-01	LGNDLIGAND PHARMACEUTICALS INCM Exercise/Conversion	CLO & Secretary	MExercise/Conversion	+5,000 sh	$52.27	+$261K	46,382
2026-05-01	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−600 sh	$227.45	−$136K	45,782
2026-05-01	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−932 sh	$228.75	−$213K	44,850
2026-05-01	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−98 sh	$229.71	−$22.5K	44,752
2026-05-01	LGNDLIGAND PHARMACEUTICALS INCS Sale	CLO & Secretary	SSale	−370 sh	$230.87	−$85.4K	44,382

Recent filings

Accepted (ET)
Oct 64
Reardon Andrew0001950232-26-000003
SEC(opens sec.gov)
Sep 84
Reardon Andrew0002001011-26-000137
SEC(opens sec.gov)
Aug 44
Reardon Andrew0002001011-26-000111
SEC(opens sec.gov)

Companies

LIGAND PHARMACEUTICALS INCCLO & SecretaryLGND

Address

555 HERITAGE DRIVE SUITE 200

JUPITER, FL, 33458